Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 16

1.

Selinexor (KPT-330) Induces Tumor Suppression through Nuclear Sequestration of IκB and Downregulation of Survivin.

Nair JS, Musi E, Schwartz GK.

Clin Cancer Res. 2017 Aug 1;23(15):4301-4311. doi: 10.1158/1078-0432.CCR-16-2632. Epub 2017 Mar 17.

2.
3.

BRD4-targeted therapy induces Myc-independent cytotoxicity in Gnaq/11-mutatant uveal melanoma cells.

Ambrosini G, Sawle AD, Musi E, Schwartz GK.

Oncotarget. 2015 Oct 20;6(32):33397-409. doi: 10.18632/oncotarget.5179.

4.

The phosphoinositide 3-kinase α selective inhibitor BYL719 enhances the effect of the protein kinase C inhibitor AEB071 in GNAQ/GNA11-mutant uveal melanoma cells.

Musi E, Ambrosini G, de Stanchina E, Schwartz GK.

Mol Cancer Ther. 2014 May;13(5):1044-53. doi: 10.1158/1535-7163.MCT-13-0550. Epub 2014 Feb 21. Erratum in: Mol Cancer Ther. 2014 Sep;13(9):2250.

5.

Inhibition of mutant GNAQ signaling in uveal melanoma induces AMPK-dependent autophagic cell death.

Ambrosini G, Musi E, Ho AL, de Stanchina E, Schwartz GK.

Mol Cancer Ther. 2013 May;12(5):768-76. doi: 10.1158/1535-7163.MCT-12-1020. Epub 2013 Feb 26.

6.

Impact of combined mTOR and MEK inhibition in uveal melanoma is driven by tumor genotype.

Ho AL, Musi E, Ambrosini G, Nair JS, Deraje Vasudeva S, de Stanchina E, Schwartz GK.

PLoS One. 2012;7(7):e40439. doi: 10.1371/journal.pone.0040439. Epub 2012 Jul 10.

7.

The cyclin-dependent kinase inhibitor flavopiridol potentiates doxorubicin efficacy in advanced sarcomas: preclinical investigations and results of a phase I dose-escalation clinical trial.

Luke JJ, D'Adamo DR, Dickson MA, Keohan ML, Carvajal RD, Maki RG, de Stanchina E, Musi E, Singer S, Schwartz GK.

Clin Cancer Res. 2012 May 1;18(9):2638-47. doi: 10.1158/1078-0432.CCR-11-3203. Epub 2012 Feb 28.

8.

Human solCD39 inhibits injury-induced development of neointimal hyperplasia.

Drosopoulos JH, Kraemer R, Shen H, Upmacis RK, Marcus AJ, Musi E.

Thromb Haemost. 2010 Feb;103(2):426-34. doi: 10.1160/TH09-05-0305. Epub 2009 Dec 18.

9.

Synthesis, characterization, and in vitro antimalarial and antitumor activity of new ruthenium(II) complexes of chloroquine.

Rajapakse CS, Martínez A, Naoulou B, Jarzecki AA, Suárez L, Deregnaucourt C, Sinou V, Schrével J, Musi E, Ambrosini G, Schwartz GK, Sánchez-Delgado RA.

Inorg Chem. 2009 Feb 2;48(3):1122-31. doi: 10.1021/ic802220w.

10.

Safingol (L-threo-sphinganine) induces autophagy in solid tumor cells through inhibition of PKC and the PI3-kinase pathway.

Coward J, Ambrosini G, Musi E, Truman JP, Haimovitz-Friedman A, Allegood JC, Wang E, Merrill AH Jr, Schwartz GK.

Autophagy. 2009 Feb;5(2):184-93. Epub 2009 Feb 6.

PMID:
19098447
11.

Constraints imposed by transmembrane domains affect enzymatic activity of membrane-associated human CD39/NTPDase1 mutants.

Musi E, Islam N, Drosopoulos JH.

Arch Biochem Biophys. 2007 May 1;461(1):30-9. Epub 2007 Mar 2.

PMID:
17374358
12.

IL-8 and MCP-1 secretion is enhanced by the peptide-nucleic acid immunomodulator, Product R, in U937 cells and primary human monocytes.

Lazzarino DA, de Diego M, Hirschman SZ, Zhang KY, Shaikh S, Musi E, Liaw L, Alexander RJ.

Cytokine. 2001 May 21;14(4):234-9.

PMID:
11448124
13.

CXCR4 and CCR5 expression by H9 T-cells is downregulated by a peptide-nucleic acid immunomodulator.

Lazzarino DA, Diego M, Musi E, Hirschman SZ, Alexander RJ.

Immunol Lett. 2000 Nov 1;74(3):189-95.

PMID:
11064099
14.

Evaluation of new product for hydroxyproline determination in HPLC.

Morleo MA, Musi E.

Boll Chim Farm. 1993 Sep;132(8):281-4.

PMID:
8217072
15.

Role of extracellular calcium on heart muscle energetics: effects of verapamil.

Ponce-Hornos JE, Musi EA, Bonazzola P.

Am J Physiol. 1990 Jan;258(1 Pt 2):H64-72.

PMID:
2301615
16.

Effect of transection in the brainstem on short-term maintenance of deoxycorticosterone-salt hypertension.

Cannata MA, Musi EA, Gomez RE.

Brain Res. 1987 Sep 15;420(2):295-301.

PMID:
3676762

Supplemental Content

Support Center